Chiropractors in Hancock, MI Accepting Medicare
4 Chiropractors found. Showing 1 - 4
 Dr. Davin Andrew Isaacson, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 101 E Quincy St, Suite 3, Hancock, MI 49930 Phone: 906-482-4900 Fax: 906-482-0601 |
Dr. James F Peterson, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 424 Quincy St, Hancock, MI 49930 Phone: 906-483-0371 |
Dr. David John Campain, D.C. Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 841 Summit St, Hancock, MI 49930 Phone: 563-676-7031 |
 Davin Isaacson, Sole Member Chiropractor Medicare: Medicare Enrolled Practice Location: 101 E Quincy St, Suite 3, Hancock, MI 49930 Phone: 906-482-4900 Fax: 906-482-0601 |
News Archive
Avicena files composition of matter patent application for treatment of Huntington's disease
Avicena Group has announced day that it has filed a composition of matter patent application with the United States Patent and Trademark Office (USPTO) to cover potential treatments for Huntington's disease, a fatal neurodegenerative disease.
Hypofractionated stereotactic radiotherapy beneficial for recurrent low-grade glioma
Hypofractionated stereotactic radiotherapy was well-tolerated and improved symptoms in patients with recurrent low-grade glioma, according to researchers from the Kimmel Cancer Center at Jefferson.
New project receives €8.65 million from EU and Canada to ease genomic, health data sharing
The European Union and the Canadian government have awarded the international iReceptor Plus consortium, which is composed of more than 20 partners, €8.65 million to promote human immunological data storage, integration and controlled sharing for a wide range of clinical and scientific purposes.
BDSI initiates dosing in BEMA Buprenorphine Phase 3 clinical program for chronic pain
BioDelivery Sciences International, Inc. today announced the enrollment and dosing of the first patient in its Phase 3 clinical program evaluating the efficacy and safety of BEMA Buprenorphine for the treatment of moderate to severe chronic pain.
Protein found in immune cells may be a reliable marker for schizophrenia risk
Schizophrenia is a severe and complex psychiatric illness that affects about 1% of the population. Diagnosis currently relies on subjective clinical interviews and the assessment of ambiguous symptoms, which frequently leads to delayed diagnosis and treatment. As such, biomarkers that would indicate schizophrenia risk or onset would be extremely useful.
› Verified 5 days ago
Physical Therapists
Speech-Language Pathologists
Chiropractors
Occupational Therapists
Audiologists
Podiatrists